Pulse Oximetry Screening for Critical Congenital Heart Defects in Newborn Babies

Anurag Girdhar; Andrew K Ewer

doi:10.1016/j.cnc.2023.09.001

Pulse Oximetry Screening for Critical Congenital Heart Defects in Newborn Babies

Crit Care Nurs Clin North Am. 2024 Mar;36(1):99-110. doi: 10.1016/j.cnc.2023.09.001. Epub 2023 Oct 17.

Authors

Anurag Girdhar¹, Andrew K Ewer²

Affiliations

¹ Department of Neonatology, Birmingham Women's Hospital NHS Trust, Birmingham, United Kingdom.
² Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

PMID: 38296378
DOI: 10.1016/j.cnc.2023.09.001

Abstract

Pulse oximetry screening (POS) was first described over 20 years ago. However, in recent years, major clinical trials have demonstrated consistent test accuracy for the detection of critical congenital heart defects (CCHD). International uptake of POS has progressed well over the last 10 years with most major high-income countries now recommending screening. This review describes the evidence base which has led to this, the current debate regarding choice of screening algorithm, and the future areas for further research.

Keywords: Congenital heart defects; Newborn; Pulse oximetry; Screening.

Publication types

Review

MeSH terms

Algorithms
Heart Defects, Congenital* / diagnosis
Humans
Infant
Infant, Newborn
Oximetry